Informed Consent Guidance Focuses On Children And Non-English Speaking Subjects
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA’s draft guidance urges consideration of ethical ramifications of enrolling or excluding potential subjects from clinical trials when there may be a language barrier.